CL2015002723A1 - Métodos para tratar la psoriasis utilizando un anticuerpo anti-il-23 - Google Patents
Métodos para tratar la psoriasis utilizando un anticuerpo anti-il-23Info
- Publication number
- CL2015002723A1 CL2015002723A1 CL2015002723A CL2015002723A CL2015002723A1 CL 2015002723 A1 CL2015002723 A1 CL 2015002723A1 CL 2015002723 A CL2015002723 A CL 2015002723A CL 2015002723 A CL2015002723 A CL 2015002723A CL 2015002723 A1 CL2015002723 A1 CL 2015002723A1
- Authority
- CL
- Chile
- Prior art keywords
- antibody
- methods
- treat psoriasis
- psoriasis
- treat
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361789777P | 2013-03-15 | 2013-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015002723A1 true CL2015002723A1 (es) | 2016-03-28 |
Family
ID=50336511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015002723A CL2015002723A1 (es) | 2013-03-15 | 2015-09-15 | Métodos para tratar la psoriasis utilizando un anticuerpo anti-il-23 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20160060337A1 (enExample) |
| EP (2) | EP2968488A1 (enExample) |
| JP (4) | JP2016517408A (enExample) |
| KR (1) | KR20150128858A (enExample) |
| CN (1) | CN105209064A (enExample) |
| AP (1) | AP2015008803A0 (enExample) |
| AU (3) | AU2014238148A1 (enExample) |
| CA (1) | CA2906382A1 (enExample) |
| CL (1) | CL2015002723A1 (enExample) |
| CR (1) | CR20150572A (enExample) |
| EA (1) | EA201591581A1 (enExample) |
| HK (1) | HK1219425A1 (enExample) |
| IL (2) | IL241342A0 (enExample) |
| PH (2) | PH12015502129A1 (enExample) |
| SG (2) | SG11201507482UA (enExample) |
| TN (1) | TN2015000403A1 (enExample) |
| WO (1) | WO2014149425A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP3953A (en) | 2010-11-04 | 2016-12-22 | Boehringer Ingelheim Int | Anti-IL-23 antibodies |
| JP6293120B2 (ja) | 2012-05-03 | 2018-03-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗ＩＬ−２３ｐ１９抗体 |
| JP2017524359A (ja) | 2014-07-24 | 2017-08-31 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｉｌ−２３ａ関連疾患の処置に有用なバイオマーカー |
| TWI711629B (zh) | 2014-09-03 | 2020-12-01 | 德商包林格因蓋爾漢國際股份有限公司 | 靶向IL-23A與TNF-α之化合物及其用途 |
| EA201791734A1 (ru) * | 2015-02-04 | 2018-01-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Способ лечения воспалительных заболеваний |
| KR20240034883A (ko) * | 2016-03-29 | 2024-03-14 | 얀센 바이오테크 인코포레이티드 | 항-il12 및/또는 항-il23 항체의 증가된 투여 간격을 사용한 건선의 치료 |
| CA3018794A1 (en) * | 2016-04-15 | 2017-10-19 | Boehringer Ingelheim International Gmbh | Use of il-23 antibodies for treating generalized pustular psoriasis |
| US20200025776A1 (en) * | 2018-07-18 | 2020-01-23 | Janssen Biotech, Inc. | Sustained Response Predictors After Treatment With Anti-IL23 Specific Antibody |
| US20210403557A1 (en) * | 2018-11-05 | 2021-12-30 | Merck Sharp & Dohme Corp. | Dosing regimen of anti-tigit antibody for treatment of cancer |
| AU2020243588B2 (en) * | 2019-03-18 | 2025-12-18 | Janssen Biotech, Inc. | Method of treating psoriasis in pediatric subjects with anti-IL12/IL23 antibody |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| PE20000183A1 (es) | 1997-07-25 | 2000-03-11 | Schering Corp | Citoquinas de mamiferos y reactivos relacionados |
| PL1896073T3 (pl) | 2005-06-30 | 2013-08-30 | Janssen Biotech Inc | Przeciwciała anty-IL-23, kompozycje, sposoby i zastosowania |
| PL1937721T3 (pl) | 2005-08-25 | 2010-12-31 | Lilly Co Eli | Przeciwciała anty-IL23 |
| US20070050011A1 (en) | 2005-08-26 | 2007-03-01 | Medlogics Device Corporation | Lumen-supporting stents and methods for creating lumen-supporting stents with various open/closed designs |
| HRP20170444T1 (hr) | 2005-08-31 | 2017-05-19 | Merck Sharp & Dohme Corp. | Projektirana anti-il-23 antitijela |
| EP1977007A4 (en) * | 2005-12-28 | 2009-11-11 | Centocor Ortho Biotech Inc | MARKERS AND METHOD FOR THE ASSESSMENT AND TREATMENT OF PSORIASIS AND RELATED DISEASES |
| DK3219328T3 (da) | 2005-12-29 | 2020-07-13 | Janssen Biotech Inc | Humane anti-il-23-antistoffer, sammensætninger, fremgangsmåder og anvendelser |
| CA2655372A1 (en) | 2006-06-13 | 2007-12-21 | Zymogenetics, Inc. | Il-17 and il-23 antagonists and methods of using the same |
| EP2064242A1 (en) * | 2007-02-23 | 2009-06-03 | Schering Corporation | Engineered anti-il-23p19 antibodies |
| MX2009009079A (es) | 2007-02-23 | 2009-08-31 | Schering Corp | Anticuerpos anti-il-23p19 de ingenieria. |
| AR068723A1 (es) | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| WO2009082624A2 (en) | 2007-12-10 | 2009-07-02 | Zymogenetics, Inc. | Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| EP2810954A3 (en) * | 2008-03-18 | 2015-03-18 | Abbvie Inc. | Methods for treating psoriasis |
| WO2010002776A2 (en) | 2008-06-30 | 2010-01-07 | Black & Decker Inc. | Cord protector for power tools |
| US8263748B2 (en) | 2008-08-27 | 2012-09-11 | Schering Corporation | Lyophilized formulations of engineered anti-IL-23p19 antibodies |
| EP2414393A1 (en) | 2009-04-01 | 2012-02-08 | Glaxo Group Limited | Anti-il-23 immunoglobulins |
| EP2435480A1 (en) | 2009-05-27 | 2012-04-04 | Ablynx N.V. | Biparatopic protein constructs directed against il-23 |
| RU2012114854A (ru) * | 2009-09-14 | 2013-10-27 | Эбботт Лэборетриз | Способы лечения псориаза |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| PT3295957T (pt) | 2010-01-15 | 2019-11-12 | Kirin Amgen Inc | Formulação de anticorpo anti il-17ra e regimes terapêuticos para o tratamento de psoríase |
| JP5972871B2 (ja) | 2010-07-20 | 2016-08-17 | テバ・ファーマシューティカルズ・オーストラリア・ピーティワイ・リミテッド | 抗ｉｌ−２３ヘテロ二量体特異的抗体 |
| CA2813208A1 (en) * | 2010-10-06 | 2012-04-12 | Abbvie Inc. | Methods for treating psoriasis |
| JP5537740B2 (ja) * | 2010-10-08 | 2014-07-02 | ノバルティス アーゲー | Ｉｌ−１７アンタゴニストを用いて乾癬を治療する方法 |
| AP3953A (en) | 2010-11-04 | 2016-12-22 | Boehringer Ingelheim Int | Anti-IL-23 antibodies |
-
2014
- 2014-02-25 EP EP14711352.6A patent/EP2968488A1/en not_active Withdrawn
- 2014-02-25 SG SG11201507482UA patent/SG11201507482UA/en unknown
- 2014-02-25 WO PCT/US2014/018293 patent/WO2014149425A1/en not_active Ceased
- 2014-02-25 JP JP2016500381A patent/JP2016517408A/ja active Pending
- 2014-02-25 EA EA201591581A patent/EA201591581A1/ru unknown
- 2014-02-25 AU AU2014238148A patent/AU2014238148A1/en not_active Abandoned
- 2014-02-25 CA CA2906382A patent/CA2906382A1/en not_active Abandoned
- 2014-02-25 US US14/776,222 patent/US20160060337A1/en not_active Abandoned
- 2014-02-25 HK HK16107479.7A patent/HK1219425A1/zh unknown
- 2014-02-25 EP EP19206477.2A patent/EP3689369A1/en not_active Withdrawn
- 2014-02-25 CN CN201480015797.0A patent/CN105209064A/zh active Pending
- 2014-02-25 KR KR1020157027833A patent/KR20150128858A/ko not_active Ceased
- 2014-02-25 SG SG10201804954UA patent/SG10201804954UA/en unknown
- 2014-02-25 AP AP2015008803A patent/AP2015008803A0/xx unknown
-
2015
- 2015-09-09 IL IL241342A patent/IL241342A0/en unknown
- 2015-09-09 TN TN2015000403A patent/TN2015000403A1/en unknown
- 2015-09-15 PH PH12015502129A patent/PH12015502129A1/en unknown
- 2015-09-15 CL CL2015002723A patent/CL2015002723A1/es unknown
- 2015-10-15 CR CR20150572A patent/CR20150572A/es unknown
-
2019
- 2019-01-11 AU AU2019200206A patent/AU2019200206A1/en not_active Abandoned
- 2019-09-24 JP JP2019172758A patent/JP2020063237A/ja active Pending
- 2019-10-10 US US16/598,714 patent/US20200277368A1/en not_active Abandoned
- 2019-11-28 PH PH12019502700A patent/PH12019502700A1/en unknown
-
2020
- 2020-06-03 IL IL275093A patent/IL275093A/en unknown
- 2020-11-18 AU AU2020270495A patent/AU2020270495A1/en not_active Abandoned
-
2021
- 2021-03-29 JP JP2021054632A patent/JP2021102644A/ja active Pending
-
2022
- 2022-01-13 US US17/574,980 patent/US20220135668A1/en not_active Abandoned
- 2022-11-02 JP JP2022175999A patent/JP2023011815A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014238148A1 (en) | 2015-10-08 |
| AP2015008803A0 (en) | 2015-10-31 |
| US20220135668A1 (en) | 2022-05-05 |
| KR20150128858A (ko) | 2015-11-18 |
| AU2020270495A1 (en) | 2020-12-17 |
| CA2906382A1 (en) | 2014-09-25 |
| IL241342A0 (en) | 2015-11-30 |
| EP3689369A1 (en) | 2020-08-05 |
| HK1219425A1 (zh) | 2017-04-07 |
| SG10201804954UA (en) | 2018-07-30 |
| SG11201507482UA (en) | 2015-10-29 |
| EP2968488A1 (en) | 2016-01-20 |
| IL275093A (en) | 2020-07-30 |
| AU2019200206A1 (en) | 2019-01-31 |
| EA201591581A1 (ru) | 2016-01-29 |
| WO2014149425A1 (en) | 2014-09-25 |
| PH12019502700A1 (en) | 2020-12-07 |
| PH12015502129A1 (en) | 2016-01-25 |
| US20160060337A1 (en) | 2016-03-03 |
| JP2020063237A (ja) | 2020-04-23 |
| CN105209064A (zh) | 2015-12-30 |
| JP2016517408A (ja) | 2016-06-16 |
| JP2023011815A (ja) | 2023-01-24 |
| TN2015000403A1 (en) | 2017-01-03 |
| US20200277368A1 (en) | 2020-09-03 |
| CR20150572A (es) | 2016-04-25 |
| JP2021102644A (ja) | 2021-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2015002723A1 (es) | Métodos para tratar la psoriasis utilizando un anticuerpo anti-il-23 | |
| MX370506B (es) | Método para tratar trastorno de estrés post-traumático. | |
| BR112015030351A2 (pt) | método e aparelho para realização de transações locais | |
| BR112015020236A2 (pt) | método e aparelho para comunicação focalizada de dados | |
| UY35787A (es) | Composiciones útiles para tratar trastornos relacionados con kit | |
| CL2015001929A1 (es) | Sistema y método optico para seleccionar semillas | |
| CL2017002728A1 (es) | Método para el tratamiento de cáncer | |
| AR091700A1 (es) | Anticuerpos e inmunoconjugados anti-cd79b | |
| CL2015003049A1 (es) | Variantes de pertuzumab y su evaluación | |
| CL2016000326A1 (es) | Composiciones y método para tratar condiciones asociadas con el complemento | |
| ES2813450T8 (es) | Compuestos y métodos para tratar un trastorno epiléptico | |
| HUE049442T2 (hu) | Módszerek eozinofil nyelõcsõgyulladás kezelésére IL-4R inhibitor beadásával | |
| EP3022216C0 (en) | IMPROVED PROCESS FOR ORGANIC SOLVENT TREATMENT OF LIGNOCELLULOSIC BIOMASS | |
| CL2015002724A1 (es) | Métodos para tratar la enfermedad de crohn utilizando un anticuerpo anti-il23 | |
| BR112013031968A2 (pt) | método e aparelho para testes magnéticos | |
| BR112016014327A2 (pt) | método e aparelho para predição de tabela de paleta | |
| BR112014000351A2 (pt) | “método para tratamento prévio de biomassa lignocelulósica” | |
| UY34661A (es) | Inhibidores de benzodioxano de la producción de leucotrieno para terapia de combinación | |
| BR112013031795A2 (pt) | método para tratar uma doença | |
| IL266607A (en) | A method for treating eczema with a specific anti-IL-23 antibody | |
| BR112013029484A2 (pt) | método para o tratamento de tumores sólidos avançados | |
| EA201690990A1 (ru) | Способы получения ингибиторов фосфатидилинозитол-3-киназы | |
| UY34708A (es) | Metodo para producir glicósidos de esteviol | |
| BR112013024363A2 (pt) | método, e aparelho | |
| BR112013023227A2 (pt) | método para tratar perda de circulação, e material de circulação perdida de gelificação (lcm) |